Cancer field is that researchers do not have

genetic and genomic research can never be completely accurate. Today’s cancer
genetic and genomic research is all based off of predictions and can lead to
false diagnoses and treatment plans, causing the patients and government a lot
of money. This testing error is a result of the program’s lack of funding. This
prevents researchers and specialist from perfecting and furthering their research
about cancer and genetic knowledge. If new testing were to be implemented, the
new data may not be an exact guarantee, but testing and treatment plans are
very important because cancer is a growing disease and in order to save the
lives of many people, risks are needed to be taken to ensure cancer genetic and
genomic research is accurate and reliable. In order to eliminate the problem of
inaccurate results and treatment options, the government would have to invest
more money into the program to see what researchers are capable of doing.

            With the constant need for cancer
genetic and genomic research, cancer information needs to be more accurate, because
doctors and specialist rely on this information to make diagnosis and treatment
plans for their patients. “The future projection of the new
genetic-molecular technologies in the field of diagnosis and precocious
detection is very limited by the lack of rigor in the research on these tests.
These problems are at the root of the reiterated false expectations which are
created around these diagnostic tests” (Lumbreras et al.). A big obstacle in this field is
that researchers do not have proper equipment to perform all the test needed to
make a reliable conclusion. In order for a specialist or doctor to make a
proper diagnosis, it is crucial for them to have data and studies to back up
their speculations. Many researchers
base their diagnosis off of past research instead of up-to-date information because
they do not have proper equipment. Relying on past information can be non-beneficial
because it is not up-to-date and could hold false information that is no longer
useful anymore, or that has been proven to be wrong. In their article, Cornell
and Val El discuss the barriers of performing new tests and research projects
without sufficient funding. These obstacles prevent researchers from conducting
new genome sequencing, forcing them to rely on previous testing to help diagnose
their patients. “In cancer screening, genetic education, and economic
evaluations, much work needs to be done for both the public health and genetics
communities to address barriers and make use of promising developments to
further a successful and responsible implementation of genetic services in
public health” (Cornell and Van El). Diagnosing
patients based on old information can be very misleading and dangerous, because
if a doctor diagnoses a patient that has the same symptoms and sequencing as
another patient thirty years ago, it does not mean that they have the same
diseases. Having a constant flow of new data and tests can be very beneficial, because
doctors can make more accurate diagnosis and create better treatment options.

We Will Write a Custom Essay Specifically
For You For Only $13.90/page!

order now

            Having a well-known cause about a
specific research field is beneficial, because if people can understand the
importance of your research, the government would be more willing to invest in
it, thus helping their financial problems. Cancer genetics and genomics is not
a well-known research project, but is essential because it monitors gene
mutations and comes up with potential treatment options before they get cancer.
“Advances in genomic analysis technologies have
led to the development of new diagnostic tests with clinical application.
Therefore, as in other diagnostic fields, awareness of the methodological
limitations of genetic investigation will facilitate the application of the
results” (Lumbreras et al.). Developing a researcher program can be very hard
in the beginning, because the government may not want to invest in a new program
due to lack of experience and the fear it might not work out. The only way for
a program to grow is to become well-know and prove they are worth being financially
supported. As the program starts to become more advanced, cancer genetic and
genomic research becomes more reliable and can start to do what the program was
made to do. “The advances derived from the Human
Genome Project have led to the development of new kinds of diagnostic tests,
genetic, molecular or proteomic, which can be incorporated into clinical
practice” (Lumbreras et al.). The medical field is advancing in many ways, in
both research or medical equipment. It is necessary for everyone in these
fields to have the proper equipment and recourses because it allows researchers
to get more accurate and up-to-date results instead of reusing data that could
be many years old. In order for new research projects to succeed, the team must
explain the importance of the research and have sufficient proposals to receive
funding. With a constant source of money, the research team can buy proper equipment
to effectively perform tests and cancer genome sequencing. Although cancer
genetic and genomic research is not a well-known organization, it is a very
important field of study and with proper supplies and equipment, researchers can
help improve the cancer genetic and genomic research organization.

Being able
to predict accurate genome sequencing and treatment options are very important,
because they can be very expensive and having to do multiple tests can result
it wrong information and expensive medical bills, but with proper government
funding, this could all be avoided. Genome testing is very expensive because it
goes through extensive research and lab work in order to read mutated DNA genes
or potential cancer diseases. “Misinterpretation could lead to unnecessary and
expensive medical interventions or to neglect in undertaking proper
preventative action” (Nordgren 63). Using outdated equipment can result in
inaccurate results and lead to many ethical and financial problems. Having sufficient
funding could help eliminate this problem and ultimately result in more
accurate readings and data. “One
single process to sequence all of our genes of interest at the same time
represents a major improvement in the laboratory organization by being less
time- and personnel-consuming. This process can also be more efficient by
proposing actionable gene analysis in addition to analysis of the principal
genes analyzed in the clinical setting” (Collet et al.). With more accurate readings, specialists can monitor gene abnormalities in order
to review the effects on the body for future studies and potential treatments
options. Having proper equipment can lead to more accurate and reliable
testing, limiting the costs of false data and treatment plans. Being able to diagnose patients correctly is why government
funding is essential for the development of cancer genetic and genomic research,
because it will provide the proper systems and equipment to make more accurate
predictions and treatment options.

A big controversy in this research field
is if researches actually get funding, will testing work or will they still be
stuck reproducing false and inaccurate information. Officials can never be sure
about genetic testing because if they are never given the chance to perform
testing, then they will never know the answer. “This study also demonstrates
that data analysis remains a major issue. Geneticists must be actively involved
in data analysis based on a good understanding of bioinformatics pipelines to
avoid reporting poor quality results” (Collet et al.). Collet and her research
team discuss the controversy between receiving funding and what they will be doing
with it. Her team talks about how researchers can do all these tests with new
equipment, but they question whether researchers can actually understand the
information and read it correctly. There is no point in spending thousands of dollars
and brand-new equipment when the people using it cannot even read the test results,
because they do not have adequate knowledge about the equipment. Since government
funding has not worked in the first place, researchers need to create a new way
to raise awareness and money.

In order for this field to be successful,
researchers will have to take care of this problem themselves. Many
organizations that suffer financially often become desperate and try things
such as asking for more money or posting flyers around town, but that never
seems to work because there is no information or moral connections with it. When
people donate money, it is often associated with something dealing with faith
or self-values, creating a strong connection so they are willing to give money
in order to help that organization. For example, “St. Jude’s institution raised more money than any
American hospital, nearly $700 million last year.” (Barrett). Many people are drawn
towards donating to St. Jude’s because their morals and self-values: feeling
obligated to donate to help those in need. With cancer genetic and genomic
research, if the public were to know more about this field and what researchers
do, society would most likely be willing to donate money since they would have a
better understanding about what they are trying to do. Researchers could host a
5k run because they usually draw in a lot of attention and would help raise
awareness about the organization. Other events researcher could host are
carnivals or benefit concerts because they bring in a lot of money and it gives
other people a chance to have fun while learning about where the proceeds are
going. In this case, the proceeds would be going to benefit the research program
by purchasing up-to-date equipment in order to produce accurate data.

Since many researchers have not had the luxury to
use new equipment, no one can be confident that funding will be beneficial. This
potential problem is due to the program’s lack of funding from the government. Working
with old equipment and data prevents researchers and specialist from perfecting
their research about cancer and genetic knowledge. In order to eliminate this
problem, the cancer genetic and genomic research organization will have to
raise money or receive more government funding so they to purchase up-to-date equipment
in pursuance of producing accurate and reliable data. Although testing can have its flaws, risks are meant
to be taken for the safety of patients and the future of medical research. Being able to diagnose patients correctly is why government
funding is essential for the development of cancer genetic and genomic research,
because it will provide the proper systems and equipment to make more accurate
predictions and treatment options.